Since STING gene is methylated in SCLC cells, resulting in reduced gene expression, it has been evaluated the possibility that demethylating agents or STING overexpression could somehow circumvent the obstacle and induce activation of immune genes. This evidence concerns the gene STING1 and small cell lung carcinoma.